Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
A method is described for the quantitation of total skeletal activity during bone scans. The method requires a single plasma sample only, taken at the time of imaging. The ratio of % injected dose of 51Cr EDTA to that of 99Tcm MDP is calculated from this sample following combined injection of the two radiopharmaceuticals. The 51Cr EDTA level corrects for the glomerular filtration of 99Tcm MDP. Using this method, which only requires a gamma counter, significant differences from normal controls have been shown in patients with osteomalacia, renal osteodystrophy, Paget's disease and hypercalcaemia. The method provides routine quantitative data to add to the imaging information in the bone scan.
D000328:Adult; D000368:Aged; D001851:Bone Diseases, Metabolic / Q000378:metabolism*; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000378:metabolism*; D002860:Chromium Radioisotopes; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000378:metabolism; D004164:Diphosphonates / Q000097:blood; D004492:Edetic Acid / Q000097:blood; D006801:Humans; D006934:Hypercalcemia / Q000378:metabolism; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D010001:Osteitis Deformans / Q000378:metabolism; D010018:Osteomalacia / Q000378:metabolism; D011877:Radionuclide Imaging; D013667:Technetium / Q000097:blood; D013669:Technetium Tc 99m Medronate
D002860:Chromium Radioisotopes; D004164:Diphosphonates; D013667:Technetium; D004492:Edetic Acid; D013669:Technetium Tc 99m Medronate